InsiderTrades

Form 4 for XENE Xenon Pharmaceuticals Inc.

Accepted 2024-03-08 00:00:00 ET · period of report 2024-03-07 · accession 0000950170-24-028788 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-03-08 2024-03-07 XENE GANNON STEVEN Dir S - Sale $46.28 -13.0K 14.0K -48% -$601.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2024-03-07 S D 5,000 $46.30 4,000 D — — (F1) The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.3025 to $46.3675, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
2 Common Common Shares 2024-03-07 S D 5,000 $46.25 9,000 D — —
3 Common Common Shares 2024-03-07 S D 2,000 $46.20 2,000 D — — (F2) The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.20 to $46.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
4 Common Common Shares 2024-03-07 S D 1,000 $46.45 14,000 D — —